News Releases - 

2012
2011
2010
2009
2008
 
04.30.12
Regulus Therapeutics Appoints Bruce Carter to its Board of Directors
 
04.23.12
Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property,
 
02.16.12
Regulus Announces New Publication Showing Potential Therapeutic Benefit of Targeting microRNA-21 in Fibrosis
 
01.05.12
Regulus Therapeutics to Present microRNA Platform and Pipeline Updates